With strong partnerships, Pharmaniaga to remain in positive territory

PETALING JAYA: The prospects of Pharmaniaga Bhd remain positive, given that the integrated pharmaceutical group’s strength in its strong partnerships and robust portfolio going forward.

This is the conclusion that MIDF Research has come to in its latest report, which added this favourable outlook was taken despite the ongoing risks of increased inflationary pressures on raw materials used in the production of medical drugs and pharmaceutical supplies, and currency exchange volatility.